Option chain shows key data for Optimi Health's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Optimi Health.

Optimi Health (OTC:OPTHF) Stock, Option Chain

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

2-2-2

Cannabis

News

Psychedelics

Press Releases

OPTHF

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Canada

Markets

LULU

Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

Psyched New - option 1

Biotech

AWKNF

BETRF

CMND

FLHLF

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

MDXXF

MNMD

RED LIGHT HOLLAND CORP by Red Light Holland Corp.

TRUFF

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans&#39; Trips And More

OPTIMI HEALTH CORP by OPTIMI HEALTH CORP.

Optimi Health Corp

General

Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research

Contracts

Optimi Health Provides Corporate Update

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules

Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder

Health Care

Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules

Small Cap

Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing

Optimi Health Awarded Drug Establishment Licence From Health Canada

Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development

CSE:OPTI

Optimi Health

Comments

Optimi Health

Optimi Health (OPTHF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga